Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Profound Medical (PROF) EBT (2023 - 2025)

Historic EBT for Profound Medical (PROF) over the last 3 years, with Q3 2025 value amounting to -$7.9 million.

  • Profound Medical's EBT rose 1449.72% to -$7.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$39.8 million, marking a year-over-year increase of 4433.7%. This contributed to the annual value of -$28.3 million for FY2024, which is 362.85% up from last year.
  • Profound Medical's EBT amounted to -$7.9 million in Q3 2025, which was up 1449.72% from -$15.6 million recorded in Q2 2025.
  • In the past 5 years, Profound Medical's EBT registered a high of $7.3 million during Q2 2023, and its lowest value of -$48.9 million during Q4 2023.
  • For the 3-year period, Profound Medical's EBT averaged around -$8.3 million, with its median value being -$6.9 million (2024).
  • Within the past 5 years, the most significant YoY rise in Profound Medical's EBT was 8844.2% (2024), while the steepest drop was 26566.9% (2024).
  • Profound Medical's EBT (Quarter) stood at -$48.9 million in 2023, then soared by 88.44% to -$5.7 million in 2024, then crashed by 38.97% to -$7.9 million in 2025.
  • Its EBT was -$7.9 million in Q3 2025, compared to -$15.6 million in Q2 2025 and -$10.7 million in Q1 2025.